Strong price action because of failed drug trials for a competitor (ANAB)
Shorting here at 8.97. Targetting 5-7. Will place a trailing stop at 7.
Shorting here at 8.97. Targetting 5-7. Will place a trailing stop at 7.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.